Sequent Scientific Limited

SEQUENT

INE807F01027

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 00:08:14 2024-05-18 EDT			5-day change	1st Jan Change
117.4 ^INR	+1.03%		+1.34%	+3.07%

05-16	Transcript : Sequent Scientific Limited, Q4 2024 Earnings Call, May 16, 2024
05-15	Sequent Scientific Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

Sequent Scientific Limited Announces Resignation of Mr. Manish Gupta from the Position of Managing Director

April 11, 2022 at 09:02 am

Sequent Scientific Limited announced that the resignation of Mr. Manish Gupta from the position of Managing Director from close of business on April 10, 2022.

Latest news about Sequent Scientific Limited

Transcript : Sequent Scientific Limited, Q4 2024 Earnings Call, May 16, 2024	05-16
Sequent Scientific Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-15	CI
Sequent Scientific Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-15	CI
Sequent Scientific's Joint Managing Director Resigns	04-04	MT
Sequent Scientific Limited Announces Resignation of Sharat Pandurang Narasapur, Jt. Managing Director, from the Board of Directors, Member of the Corporate Social Responsibility Committee of the Board Effective on April 30, 2024	04-04	CI
Transcript : Sequent Scientific Limited, Q3 2024 Earnings Call, Feb 15, 2024	02-15
Sequent Scientific Limited Announces Executive Changes	02-13	CI
Sequent Scientific Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-13	CI
Sequent Scientific Limited Announces Resignation of Krunal Shah as Company Secretary & Compliance Officer, Effective on February 15, 2024	12-06	CI
Sequent Scientific Appoints CFO	11-06	MT
Transcript : Sequent Scientific Limited, Q2 2024 Earnings Call, Nov 07, 2023	11-06
Sequent Scientific's CFO Resigns	23-10-17	MT
Sequent Scientific Limited Announces Patri Venkat Raghavendra Rao as Chief Financial Officer	23-10-16	CI
Transcript : Sequent Scientific Limited, Q1 2024 Earnings Call, Aug 11, 2023	23-08-10
Sequent Scientific Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10	CI
Sequent Scientific Discontinues Manufacturing Operations at Tarapur Unit in India	23-07-16	MT
Sequent Scientific Limited Announces Discontinuation of Manufacturing Operations At Tarapur, Maharashtra	23-07-14	CI
Transcript : Sequent Scientific Limited, Q4 2023 Earnings Call, May 24, 2023	23-05-23
Sequent Scientific Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-23	CI
INDIA STOCKS-Indian shares fall on rate fears after Powell reiterates hawkish message	23-03-08	RE
SeQuent Scientific Terminates Agreement to Acquire Tineta Pharma	23-03-08	MT
Indian shares set for muted start as Powell reiterates hawkish message	23-03-08	RE
Sequent Scientific Limited cancelled the acquisition of Tineta Pharma Private Limited from group of shareholders.	23-03-07	CI
Transcript : Sequent Scientific Limited, Q3 2023 Earnings Call, Feb 15, 2023	23-02-14
Sequent Scientific Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI

Chart Sequent Scientific Limited

Duration

Period

More charts

SeQuent Scientific Limited is an India-based animal health company. The Company provides a wide range of animal health products, including finished dose formulations, active pharmaceutical ingredients (APIs), as well as analytical services. The Company operates through the pharmaceuticals segment. The Company is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It is specialized in analytical and bio analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It provides analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer developed methods or in-house method development. Its subsidiaries include Alivira Animal Health Limited and SeQuent Research Limited.

Sector

Pharmaceuticals

Calendar

2024-08-07 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SEQUENT SCIENTIFIC LIMITED	+3.07%	349M
ELI LILLY AND COMPANY	+32.09%	694B
NOVO NORDISK A/S	+29.39%	593B
JOHNSON & JOHNSON	-1.34%	371B
MERCK & CO., INC.	+20.34%	331B
ABBVIE INC.	+7.39%	290B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	209B
NOVARTIS AG	+10.02%	209B
AMGEN INC.	+8.49%	169B

Other Pharmaceuticals